SCHEMBL14539748

SCHEMBL14539748

CC(C)(C)OC(=O)CC[C@@H](NC(=O)OC(C)(C)C)C(N)=O

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSK P43235 11/20 0.47
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
HTT P42858 1/20 0.46
CYP2D6 P10635 1/20 0.44
CTSS P25774 5/20 0.43
CA1 P00915 1/20 0.41
CA2 P00918 1/20 0.41
CA7 P43166 1/20 0.41
CTSL P07711 1/20 0.40
CTSB P07858 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
HSD17B10 Q99714 1/20 0.39
PPARG P37231 1/20 0.39
PPARA Q07869 1/20 0.39
CAPN1 P07384 1/20 0.39
REN P00797 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27541323 1.00 CTSK (0.47) CTSKCYP1A2CYP2C9CYP2C19HTT
SCHEMBL14539642 1.00 CTSK (0.47) CTSKCYP1A2CYP2C9CYP2C19HTT
SCHEMBL20608551 0.92 CTSK (0.46) CTSKCYP1A2CYP2C9CYP2C19HTT
SCHEMBL11169650 0.92 CTSK (0.46) CTSKCYP1A2CYP2C9CYP2C19HTT
SCHEMBL27370835 0.92 CTSK (0.46) CTSKCYP1A2CYP2C9CYP2C19HTT
SCHEMBL22382062 0.89 CTSK (0.48) CTSKCYP1A2CYP2C9CYP2C19HTT
SCHEMBL13263354 0.89 CTSK (0.44) CTSKCYP1A2CYP2C9CYP2C19HTT
SCHEMBL22186263 0.88 CTSK (0.43) CTSKCYP1A2CYP2C9CYP2C19HTT
SCHEMBL11165568 0.88 CTSK (0.46) CTSKCYP1A2CYP2C9CYP2C19HTT
SCHEMBL8461423 0.87 CTSK (0.47) CTSKCYP1A2CYP2C9CYP2C19HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2007044893-A2 COMPOUNDS AND METHODS FOR INHIBITING HEPATITIS C VIRAL REPLICATION INTERMUNE, INC. (US) 2007-04-19 WO disclosed